Atopic Dermatitis Clinical Trials Market
According to Intent Market Research, the Atopic Dermatitis Clinical Trials Market is expected to grow from USD 1.6 billion in 2023 at a CAGR of 14.7% to touch USD 4.1 billion by 2030. The Atopic Dermatitis Clinical Trials Market is dominated by key players such as Pfizer Inc., Sanofi S.A., Regeneron Pharmaceuticals, Inc., Novartis AG, AbbVie Inc., LEO Pharma A/S, AstraZeneca plc, GlaxoSmithKline plc, Incyte Corporation, Dermavant Sciences, Inc., Boehringer Ingelheim GmbH, Galderma Laboratories, L.P., Takeda Pharmaceutical Company Limited.